AACR Annual Meeting 2018
Meet InSphero CSO Patrick Guye and 3D Oncology Experts Irina Agarkova and Francesca Chiavaro at AACR 2018 to learn how you can optimize your use of 3D™ InSight tumor models and services.
EASL The International Liver Congress 2018
Meet InSphero 3D liver and islet disease experts Radina Kostadinova, Monika Kijanska, and Burcak Yesildag at the International Liver Congress 2018. You can find us in the poster hall, where we’ll be presenting about advanced tools for liver and metabolic disease modeling, and leading an innovation workshop on “defeating the animal.”
Organs and Tissues on Chips (Keystone D1 2018)
Meet InSphero Head of Technology Platforms and the lead developer behind our new organs-on-chips solution at the Keystone D1 symposium and learn about the many exciting developments in this hot new field.
SOT 57th Annual Meeting and ToxExpo 2018
Meet InSphero 3D Toxicology Experts Simon Messner and Monika Kijanska, at SOT 2018 to learn how you can optimize your use of 3D™ InSight models and services.
Frontiers in Islet Biology and Diabetes (Keystone B3 2018)
Join InSphero Islet Microtissue Product Manager Burcak Yesildag and Field Application Scientist Sue Grepper at the Keystone B3 symposium for four days of full immersion into the crucial aspects of islet cell biology.
SLAS2018 International Conference and Exhibition
Meet InSphero at SLAS2018, the annual meeting of the Society of Laboratory Automation & Screening. This year, InSphero scientists will be teaching short courses, leading tutorials, and giving scientific podium presentations. We’ll also be at Booth #1614, ready to answer your questions about our scalable 3D technology and proven, cost-effective applications for pharma.
Organ Crosstalk in Obesity and NAFLD (Keystone J3 2018)
Meet InSphero Chief Scientific Officer Dr. Patrick Guye at the Keystone Symposium on Organ Crosstak in Obesity and NAFLD (J3), held in conjunction this year with the meeting on bioenergetics and Metabolic Disease (J4). Dr. Guye will be available throughout the meeting to discuss the latest advances in 3D models for studying metabolic diseases.